Literatur Review : Penggunaan Donor Sel Telur dalam Program IVF  pada Wanita dengan Kegagalan Ovarium Prematur

Rani Wijayanti; Azniah Syam

doi:10.61132/protein.v3i3.1575

Authors

Rani Wijayanti Universitas Mega Buana Palopo
Azniah Syam Universitas Mega Buana Palopo https://orcid.org/0000-0002-8451-3895

DOI:

https://doi.org/10.61132/protein.v3i3.1575

Keywords:

Egg Donor, IVF, Premature Ovarian Failure, Infertility

Abstract

Premature ovarian failure (POF) is a condition where the ovaries stop functioning before the age of 40 years, resulting in permanent infertility. IVF with own eggs in POF patients has a very low success rate, so egg donation is the most effective alternative. This review aims to evaluate the effectiveness of using egg donors in IVF programs in women with POF, through an analysis of 20 studies systematically selected from international scientific databases. The results of the study showed that egg donation consistently increased the clinical pregnancy and live birth rates in POF patients, although accompanied by obstetric risks such as gestational hypertension and preeclampsia. New reproductive technologies such as in vitro maturation (IVM), stem cell therapy, and platelet-rich plasma (PRP) also provide additional prospects for restoring ovarian function. In conclusion, egg donation is a major strategy in the management of infertility due to POF, which requires the support of an integrated clinical, ethical, and policy approach.

Downloads

Download data is not yet available.

References

Cakmak, H., Katz, A., Cedars, M. I., & Rosen, M. P. (2018). Effective use of oocyte donation in women with premature ovarian insufficiency. Fertility and Sterility, 109(4), 625–632. https://doi.org/10.1016/j.fertnstert.2018.01.013

Das, M., & Son, W. Y. (2023). In vitro maturation (IVM) of human immature oocytes: Is it still relevant? Reproductive Biology and Endocrinology, 21(1), 1–16. https://doi.org/10.1186/s12958-023-01162-x

Domingues, T. S., Aquino, A. P., Barros, B., Mazetto, R., Nicolielo, M., Kimati, C. M., Devecchi, T., Bonetti, T. C. S., Serafini, P. C., & Motta, E. L. A. (2017). Egg donation of vitrified oocytes bank produces similar pregnancy rates by blastocyst transfer when compared to fresh cycle. Journal of Assisted Reproduction and Genetics, 34(11), 1553–1557. https://doi.org/10.1007/s10815-017-1017-0

Donnez, J., Dolmans, M. M., & Pellicer, A. (2021). Oocyte donation for women with premature ovarian insufficiency: Ethical and practical issues. Human Reproduction Update, 27(1), 1–12. https://doi.org/10.1093/humupd/dmaa033

Ebrahimi, M., & Asbagh, F. A. (2011). Pathogenesis and causes of premature ovarian failure: An update. International Journal of Fertility & Sterility, 5(3), 109–120.

Egbe, T. O., Wafo, C. Y., Bollo, B. B., Pany, C., Onomo, M. J., & Sandjon, G. (2020). Successful pregnancy with donor eggs in-vitro fertilization after premature ovarian insufficiency in a tertiary hospital in a low-income setting: A case report. Fertility Research and Practice, 2(1), 1–6. https://doi.org/10.1186/s40738-016-0028-3

Hariani, N. (2022). Peran genetika molekuler dalam perspektif konservasi keanekaragaman hayati. Penerbit NEM.

Hatırnaz, S., Ata, B., Hatırnaz, E., Başbuğ, A., Tannus, S., & Tıraş, B. (2019). Dual oocyte retrieval and embryo transfer in the same cycle for women with premature ovarian insufficiency. International Journal of Gynecology & Obstetrics, 147(2), 239–244.

Hatırnaz, Ş., Başaran, M., & Yaralı, H. (2019). Dual oocyte retrieval and embryo transfer in the same cycle for women with premature ovarian insufficiency: A novel approach. International Journal of Gynecology & Obstetrics, 147(3), 408–412.

Hatırnaz, Ş., Yaralı, H., Başaran, M., & Yakin, K. (2018). Outcomes of random start versus clomiphene citrate and gonadotropin cycles in occult POI patients refusing oocyte donation: A retrospective study. Gynecological Endocrinology, 34(11), 964–968.

Ishizuka, B., Okada, H., & Hasegawa, T. (2021). Live birth rate in patients with premature ovarian insufficiency during long-term follow-up under hormone replacement with or without ovarian stimulation. Frontiers in Endocrinology, 12, 732205.

Jiang, C., Gao, T., Wang, Y., Wang, L., & Liu, X. (2024). Birth weight and premature ovarian insufficiency: A systematic review and meta-analysis. Journal of Ovarian Research, 17, 74.

Kawamura, K., Kawamura, N., & Hsueh, A. J. (2016). Activation of dormant follicles: A new treatment for premature ovarian failure? Current Opinion in Obstetrics and Gynecology, 28(3), 217–222.

Kim, H. K., & Lee, J. H. (2024). Current status and future prospects of stem cell therapy for infertile patients with premature ovarian insufficiency. Biomolecules, 14(1), 18.

Kim, T. J. (2023). Effects of autologous stem cell therapy for fertility enhancement among women with premature ovarian insufficiency. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 12(3), 765–770.

Mawet, M., Perrier d'Hauterive, S., Henry, L., & Englert, Y. (2020). Restoration of fertility in patients with spontaneous premature ovarian insufficiency: New techniques under the microscope. Journal of Clinical Medicine, 9(12), 3957.

Moustaki, M., Kontogeorgi, A., Tsangkalova, G., Bountris, P., Kanaka-Gantenbein, C., & Chrousos, G. (2023). Biological therapies for premature ovarian insufficiency: What is the evidence? Frontiers in Reproductive Health, 5, 1194575.

Moustaki, M., Kontogeorgi, A., Tsangkalova, G., Tzoupis, H., Makrigiannakis, A., Vryonidou, A., & Kalantaridou, S. N. (2023). Biological therapies for premature ovarian insufficiency: What is the evidence? Frontiers in Reproductive Health, 5, 1154959.

Robin, F. K., Andrade, G. M., Bos Mikich, A., Frantz, N., Zocche, D. A. A., & Leal, S. M. C. (2023). Donor oocyte cycle characteristics and outcomes: Factors potentially linked with successful endings. JBRA Assisted Reproduction, 27(3), 345–352.

Santoro, N., & Welt, C. K. (2010). Autoimmunity and premature ovarian failure. Autoimmunity Reviews, 9(7), 476–480.

Stoop, D., et al. (2020). Pregnancy outcomes following oocyte donation: A systematic review. Journal of Assisted Reproduction and Genetics, 37(5), 1045–1056.

Sun, B., Li, L., Zhang, Y., Wang, F., & Sun, Y. (2024). Pregnancy outcomes in women with primary ovarian insufficiency in assisted reproductive technology therapy: A retrospective study. Frontiers in Endocrinology, 15(April). https://doi.org/10.3389/fendo.2024.XXXXXXX

Sun, L., Zhang, W., Wang, Q., Zhou, Y., & Han, X. (2024). Pregnancy outcomes in women with POI in ART therapy: A retrospective study. Frontiers in Endocrinology, 15, 1343803.

Ubaldi, F. M., Rienzi, L., Ferrero, S., et al. (2023). Advanced maternal age and embryo aneuploidy: Clinical implications. Human Reproduction, 38(4), 689–698.

Wang, H., Zhang, Y., Liu, L., & Zhao, X. (2024). Effect of intra ovarian injection of platelet rich plasma on the patients with a poor ovarian response (POR) or premature ovarian insufficiency (POI): A systematic review and meta analysis. Middle East Fertility Society Journal, 29(1), 1–10. https://doi.org/10.1186/s43043-024-00256-6

Yahyavi, Y., Kheradi, N., Karimi, A., Ebrahimi-Kalan, A., Ramezani, F., Yousefi, S., Nobari, S. T., Sadrekarimi, H., Nouri, M., & Edalati, M. (2024). Novel advances in cell-free therapy for premature ovarian failure (POF): A comprehensive review. Advanced Pharmaceutical Bulletin, 14(3), 543–557. https://doi.org/10.34172/apb.2024.059

Yang, X., Wu, X., Huang, Q., & Huang, Q. (2021). Premature ovarian insufficiency: Past, present, and future. Frontiers in Cell and Developmental Biology, 9, 672890.

Zhu, X., Chen, C., & Cui, Y. (2021). Premature ovarian insufficiency patients with viable embryos derived from autologous oocytes could achieve live births via IVF: A case series and literature review. Annals of Translational Medicine, 9(6), 478.

Zhu, X., Ye, J., & Fu, Y. (2021). Premature ovarian insufficiency patients with viable embryos derived from autologous oocytes through repeated oocyte retrievals could obtain reasonable cumulative pregnancy outcomes following frozen-embryo transfer. Annals of Translational Medicine, 9(7), 539. https://doi.org/10.21037/atm-20-1112